Gastrointestinal Complications Depending on the Selectivity of Non-Steroidal Anti-Inflammatory Drug

G.V. Dzyak, Yu.M. Stepanov, I.V. Kushnirenko

Abstract


The article deals with the problem of gastrointestinal complications during administration of nonsteroidal anti-inflammatory drugs, commonly used to treat a range of conditions, particularly rheumatic diseases. The results of own researches, which served to define the characteristics of changes in the state of gastric secretory function in patients receiving non-selective and selective anti-inflammatory agent and their comparative analysis, are provided. The data obtained demonstrated a certain contribution to the understanding of the mechanism of development of complications from the gastrointestinal tract when taken drugs of above group.


Keywords


non-steroidal anti-inflammatory drugs; gastrointestinal complications; mucosa

References


Gupta S. Management of Nonsteroidal, Anti-inflammatory, Drug-Associated Dyspepsia / S. Gupta, K. McQuaid // Gastroenterology. — 2005. — Vol. 129, Issue 5. — P. 1711-1719.

The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia (the Canadian Adult Dyspepsia Empiric Treatment — Prompt Endoscopy (CADET-PE) study) / A.B. Thomson, A.N. Barkun, D. Armstrong [et al.] // Aliment. Pharmacol. Ther. — 2003. — № 17. — P. 1481-1491

Etiological factors of duodenal and gastric ulcers / A. Uyanikoğlu, A. Danalioğlu, F. Akyüz [et al.] // Turk. J. Gastroenterol. — 2012 Apr. — 23 (2). — P. 99-103.

Bjarnason I. Gastrointestinal safety of NSAIDs and over-the-counter analgesics / I. Bjarnason // Int. J. Clin. Pract. Suppl. — 2013 Jan. — 178. — P. 37-42.

Wallace J.L. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? / J.L. Wallace // Physiol. Rev. — 2008. — № 88 (4). — P. 1547-1565.

Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346) / J.L. Wallace, G. Caliendo, V. Santagada [et al.] // Br. J. Pharmacol. — 2010. — № 159 (6). — P. 1236-1246.

Determinants of the short-term gastric damage caused by NSAIDs in man / I. Bjarnason, C. Scarpignato, K. Takeuchi [et al.] // Alimentary Pharmacology & Therapeutics. — 2007. — Vol. 26, Issue 1. — P. 95-106.

Managing the Adverse Effects of Nonsteroidal Anti-inflammatory Drugs / P. Patrignani, S. Tacconelli, A. Bruno [et al.]// Expert Rev. Clin. Pharmacol. — 2011. — № 4 (5). — P. 605-621.

Aantiinflammatory drug (NSAID) induced mucosal injuries in stomach and small intestine / H. Matsui, O. Shimokawa, T. Kaneko [et al.] // J. Clin. Biochem. Nutr. — 2011. — Vol. 48, № 2. — P. 107-111.

Present status and strategy of NSAIDs-induced small bowel injury / K. Higuchi, E. Umegaki, T. Watanabe [et al.] // J. Gastroenterol. — 2009. — № 44 (9). — P. 879-888.

Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study / L. Maiden, B. Thjodleifsson, A. Seigal [et al.] // Clin Gastroenterol Hepatol. — 2007 Sep. — 5 (9). — P. 1040-1045.

Lim Y.J. Non-Steroidal Anti-Inflammatory Drug-Induced Enteropathy / Y.J. Lim, Ch.-H. Yang // Clin. Endosc. — 2012 June. — 45 (2). — P. 138-144.

Reuter B.K. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation / B.K. Reuter, N.M. Davies, J.L. Wallace // Gastroenterology. — 1997 Jan. — 112 (1). — P. 109-117.

Nylander O. The impact of cyclooxygenase inhibition on duodenal motility and mucosal alkaline secretion in anaesthetized rats / O. Nylander // Acta Physiol. (Oxf.). — 2011. — № 201 (1). — P. 179-192.

Satoh H. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility / H. Satoh, K. Amagase, K. Takeuchi // J. Pharmacol. Exp. Ther. — 2012 Nov. — 343 (2). — P. 270-277.

Jarupongprapa S. Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis / S. Jarupongprapa, P. Ussavasodhi, W. Katchamart // J. Gastroenterol. — 2012. — Dec 4. — Режим доступу до джерела: http://link.springer.com/article/10.1007%2Fs00535-012-0717-6.

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study / F.E. Silverstein, G. Faich, J.L. Goldstein [et al.] // JAMA. — 2000 Sep 13. — 284 (10). — P. 1247-1255.

The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs / van der Linden M.W., van der Bij S., Welsing P. [et al.] // Ann. Rheum. Dis. — 2009 May. — 68 (5). — P. 668-673.

Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis / T. Turajane, R. Wongbunnak, T. Patcharatrakul [et al.] // J. Med. Assoc. Thai. — 2009 Dec. — 92. — Suppl. 6. — P. S19-26.

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial / F.K. Chan, A. Lanas, J. Scheiman [et al.] // Lancet. — 2010 Jul 17. — 376 (9736). — P. 173-179.




DOI: https://doi.org/10.22141/2308-2097.1.47.2013.86239

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта